Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region (Europe. APAC, MEA), And Segment Forecasts, 2025 - 2030

Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region (Europe. APAC, MEA), And Segment Forecasts, 2025 - 2030


Canine Orthopedics Market Growth & Trends

The global canine orthopedics market size is estimated to reach USD 661.82 million by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Some of the drivers attributing to the market growth include rising pet dog ownership, the number of veterinary surgeries across the globe, initiatives by key companies, and orthopedic disorders in pet dogs. In February 2022, the MedTech segment of Vimian Group-Movora acquired IMEX Veterinary, Inc-a veterinary orthopedic implants supplier in the U.S. This complemented the company’s portfolio and enabled Movora to enter a new niche segment within surgical products. Post-acquisition, IMEX became the 4th company in the Movora family of brands that include Veterinary Orthopedic Implants, KYON AG, and BioMedtrix, LLC.

The COVID-19 pandemic led to a decrease in revenue for market players in the market. This was due to cancellation or delay in elective surgical procedures during 2020. Other challenges faced by key companies included logistical bottlenecks and dampened demand. The market, however, recovered gradually to pre-COVID numbers during 2021. In addition, the COVID-19 pandemic has catalyzed pet ownership according to findings of the Pet Food Manufacturers Association (PFMA), U.K. This is expected to contribute to market growth. The findings of the two surveys conducted in 2020 by the PFMA during the COVID-19 crisis confirmed a surge in pet ownership in the U.K. Around 3.2 million households or 11% of people brought home a pet since the start of the pandemic.

Increasing numbers of veterinary hospitals and clinics offering orthopedic surgeries for dogs are anticipated to propel the market growth. Sirius Veterinary Orthopedic Center in the U.S., for instance, is a referral-only small animal clinic specializing in orthopedic procedures. The clinic provides treatment for conditions including fractures, injuries, degeneration in the patella, meniscus, cranial cruciate ligament, hip dysplasia or luxation, joint infections, osteoarthritis, and other degenerative conditions. Veterinary Orthopedic and Surgical Care Center in the U.S. performs a range of veterinary surgeries. More than 1000 corrective osteotomies have been performed by the Center making ACL surgeries the most common at the facility.

Canine Orthopedics Market Report Highlights
  • The rising prevalence and incidence of chronic diseases, sports injuries, and trauma in pet dogs is one of the key contributing factors to the market growth
  • The implants segment held the largest revenue share of the market in 2024. This is due to the growing use of implants in orthopedic surgeries in canines
  • BioMedtrix, for example, offers Cemented Fixation (CFX) and Biologic Fixation (BFX) Total Hip System for hip replacement surgeries in companion animals. Since the product’s launch, over 54,000 procedures have been performed globally, with about 95% of pet patients completely recovering
  • The application segment was dominated by TPLO with a revenue share of 28.59% in 2024, on account of the growing use of TPLO implants and instruments in pet dogs
  • Queensland Veterinary Specialists based in Australia offer multiple types of cruciate surgery such as TTA, TPLO, CBLO, Lateral suture, and TTO. However, they recommend TPLO over other techniques because of its published evidence relating to low infection rates, low late meniscal injury rates, and extremely rare implant-related issues.
  • By end-use, the veterinary hospitals and clinics segment accounted for the largest revenue share of the global market in 2024.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing prevalence of cardiovascular diseases
3.3.1.2. Technological advancements
3.3.1.3. Aging population
3.3.2. Market restraint analysis
3.3.2.1. Regulatory challenges
3.3.2.2. High cost of development
3.4. Cardiovascular Devices Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Pipeline Analysis
Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis
4.1. Cardiovascular Devices Market: Key Takeaways
4.2. Cardiovascular Devices Market: Movement & Market Share Analysis, 2024 & 2030
4.3. Diagnostic and Monitoring Devices
4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. ECG
4.3.1.1.1. ECG market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2. Implantable Cardiac Monitors
4.3.1.2.1. Implantable cardiac monitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.3. Holter Monitors
4.3.1.3.1. Holter monitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.4. Mobile Cardiac Telemetry
4.3.1.4.1. Mobile cardiac telemetry market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.5. MRI
4.3.1.5.1. MRI estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.6. Cardiovascular Ultrasound
4.3.1.6.1. Cardiovascular ultrasound market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.6.2. 2D
4.3.1.6.2.1. 2D market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.6.3. 3D/4D
4.3.1.6.3.1. 3D/4D market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.6.4. Doppler
4.3.1.6.4.1. Doppler market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.7. Cardiac Diagnostic Catheters
4.3.1.7.1. Cardiac diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.8. PET Scanner
4.3.1.8.1. PET scanner market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Surgical Devices
4.4.1. Surgical devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.1. Cardiac Resynchronization Therapy (CRT)
4.4.1.1.1. Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.1.2. CRT-Defibrillator
4.4.1.1.2.1. CRT-defibrillator market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.1.3. CRT-Pacemaker
4.4.1.1.3.1. CRT-pacemaker market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2. Implantable Cardioverter Defibrillators (ICDs)
4.4.1.2.1. Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2.2. Single Chamber ICDs
4.4.1.2.2.1. Single chamber ICDs market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2.3. Dual Chamber ICDs
4.4.1.2.3.1. Dual chamber ICDs market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.3. Pacemakers
4.4.1.3.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.3.2. Conventional Pacemakers
4.4.1.3.2.1. Conventional pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.3.3. Leadless Pacemakers
4.4.1.3.3.1. Leadless pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.4. Coronary Stents
4.4.1.4.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.5. Catheters
4.4.1.5.1. Catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.6. Guidewires
4.4.1.6.1. Guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.7. Cannula
4.4.1.7.1. Cannula market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.8. Valves
4.4.1.8.1. Valves market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.9. Occlusion devices
4.4.1.9.1. Occlusion devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country and Product
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Norway
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. India
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Australia
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Argentina
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. Mexico
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.7.3. UAE
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.7.4. Kuwait
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2024
6.3. Market Participant Categorization
6.3.1. Abbott
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. GE HealthCare
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Edwards Lifesciences Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. W. L. Gore & Associates, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Siemens Healthcare GmbH
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. BIOTRONIK SE & Co. KG
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Canon Medical Systems Asia Pte. Ltd.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. B. Braun SE
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. LivaNova PLC
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Cardinal Health
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Medtronic
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Boston Scientific Corporation
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings